FORMA POSOLOGICA DE LIBERACION CONTINUA CON RECUBRIMIENTO DE LATEX Y SU PROCEDIMIENTO DE REALIZACION
Una unidad de forma de dosificación para administrar un agente beneficioso en un fluido, consistiendo la unidad de forma de dosificación en: un núcleo que contiene al menos un agente beneficioso dispersable en un fluido y un agente ligante compatible para unir el agente beneficioso y un revestimient...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ARNHOLT, BARBARA, S EVANS, MONTY, L MAZER, TERRY, B WALTON, JOSEPH, E HAMILTON, DANIEL GECKLE, RONITA, K |
description | Una unidad de forma de dosificación para administrar un agente beneficioso en un fluido, consistiendo la unidad de forma de dosificación en: un núcleo que contiene al menos un agente beneficioso dispersable en un fluido y un agente ligante compatible para unir el agente beneficioso y un revestimiento de látex que envuelve el núcleo, incluyendo el revestimiento de látex una mezcla que contiene un material básico substancialmente hidrofóbico capaz de definir una membrana de tipo matriz y al menos un componente hidrofílico dispersable en el fluido, donde el agente beneficioso es un tinte marcador, o donde el agente beneficioso es un componente saborizante fluorescente.
Dosage form unit is provided to deliver one or more beneficial agents into a fluid, such as liquid enteral nutritional product. The dosage form unit includes a core containing at least one beneficial agent, preferably a marker dye, which is dispersible in the fluid. The core also contains a compatible binding agent to bind the beneficial agent together. Additional components of the core may include a plasticizer, a standard flow agent, a lubricant, additional tableting aids and at least one hydrophilic agent. A latex coating encases the core. The latex coating includes a mixture containing a substantially hydrophobic base material, preferably formed from an emulsion of cellulose acetate microspheres, which is capable of defining a matrix-type membrane, and at least one hydrophilic component being dispersible in the fluid. A dispersible beneficial agent is preferred as one of the hydrophilic components of the latex coating to allow immediate release of the beneficial agent therefrom. A method of making the dosage form unit also is provided. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2248094TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2248094TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2248094TT33</originalsourceid><addsrcrecordid>eNrjZEhx8w_ydVQI8A_29_F393R2VHBxVfDxdHINcnT29PdTcPb3C_H0C3UEMRSCXJ1DnYI8fT1d_UL8wQodQ1wjFCIVgkMVAoL8nV1dkOSCXB19PKPApvAwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUknjXYCMjEwsDS5OQEGNjYtQAAEQBNNo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMA POSOLOGICA DE LIBERACION CONTINUA CON RECUBRIMIENTO DE LATEX Y SU PROCEDIMIENTO DE REALIZACION</title><source>esp@cenet</source><creator>ARNHOLT, BARBARA, S ; EVANS, MONTY, L ; MAZER, TERRY, B ; WALTON, JOSEPH, E ; HAMILTON, DANIEL ; GECKLE, RONITA, K</creator><creatorcontrib>ARNHOLT, BARBARA, S ; EVANS, MONTY, L ; MAZER, TERRY, B ; WALTON, JOSEPH, E ; HAMILTON, DANIEL ; GECKLE, RONITA, K</creatorcontrib><description>Una unidad de forma de dosificación para administrar un agente beneficioso en un fluido, consistiendo la unidad de forma de dosificación en: un núcleo que contiene al menos un agente beneficioso dispersable en un fluido y un agente ligante compatible para unir el agente beneficioso y un revestimiento de látex que envuelve el núcleo, incluyendo el revestimiento de látex una mezcla que contiene un material básico substancialmente hidrofóbico capaz de definir una membrana de tipo matriz y al menos un componente hidrofílico dispersable en el fluido, donde el agente beneficioso es un tinte marcador, o donde el agente beneficioso es un componente saborizante fluorescente.
Dosage form unit is provided to deliver one or more beneficial agents into a fluid, such as liquid enteral nutritional product. The dosage form unit includes a core containing at least one beneficial agent, preferably a marker dye, which is dispersible in the fluid. The core also contains a compatible binding agent to bind the beneficial agent together. Additional components of the core may include a plasticizer, a standard flow agent, a lubricant, additional tableting aids and at least one hydrophilic agent. A latex coating encases the core. The latex coating includes a mixture containing a substantially hydrophobic base material, preferably formed from an emulsion of cellulose acetate microspheres, which is capable of defining a matrix-type membrane, and at least one hydrophilic component being dispersible in the fluid. A dispersible beneficial agent is preferred as one of the hydrophilic components of the latex coating to allow immediate release of the beneficial agent therefrom. A method of making the dosage form unit also is provided.</description><edition>4</edition><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060316&DB=EPODOC&CC=ES&NR=2248094T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060316&DB=EPODOC&CC=ES&NR=2248094T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ARNHOLT, BARBARA, S</creatorcontrib><creatorcontrib>EVANS, MONTY, L</creatorcontrib><creatorcontrib>MAZER, TERRY, B</creatorcontrib><creatorcontrib>WALTON, JOSEPH, E</creatorcontrib><creatorcontrib>HAMILTON, DANIEL</creatorcontrib><creatorcontrib>GECKLE, RONITA, K</creatorcontrib><title>FORMA POSOLOGICA DE LIBERACION CONTINUA CON RECUBRIMIENTO DE LATEX Y SU PROCEDIMIENTO DE REALIZACION</title><description>Una unidad de forma de dosificación para administrar un agente beneficioso en un fluido, consistiendo la unidad de forma de dosificación en: un núcleo que contiene al menos un agente beneficioso dispersable en un fluido y un agente ligante compatible para unir el agente beneficioso y un revestimiento de látex que envuelve el núcleo, incluyendo el revestimiento de látex una mezcla que contiene un material básico substancialmente hidrofóbico capaz de definir una membrana de tipo matriz y al menos un componente hidrofílico dispersable en el fluido, donde el agente beneficioso es un tinte marcador, o donde el agente beneficioso es un componente saborizante fluorescente.
Dosage form unit is provided to deliver one or more beneficial agents into a fluid, such as liquid enteral nutritional product. The dosage form unit includes a core containing at least one beneficial agent, preferably a marker dye, which is dispersible in the fluid. The core also contains a compatible binding agent to bind the beneficial agent together. Additional components of the core may include a plasticizer, a standard flow agent, a lubricant, additional tableting aids and at least one hydrophilic agent. A latex coating encases the core. The latex coating includes a mixture containing a substantially hydrophobic base material, preferably formed from an emulsion of cellulose acetate microspheres, which is capable of defining a matrix-type membrane, and at least one hydrophilic component being dispersible in the fluid. A dispersible beneficial agent is preferred as one of the hydrophilic components of the latex coating to allow immediate release of the beneficial agent therefrom. A method of making the dosage form unit also is provided.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZEhx8w_ydVQI8A_29_F393R2VHBxVfDxdHINcnT29PdTcPb3C_H0C3UEMRSCXJ1DnYI8fT1d_UL8wQodQ1wjFCIVgkMVAoL8nV1dkOSCXB19PKPApvAwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUknjXYCMjEwsDS5OQEGNjYtQAAEQBNNo</recordid><startdate>20060316</startdate><enddate>20060316</enddate><creator>ARNHOLT, BARBARA, S</creator><creator>EVANS, MONTY, L</creator><creator>MAZER, TERRY, B</creator><creator>WALTON, JOSEPH, E</creator><creator>HAMILTON, DANIEL</creator><creator>GECKLE, RONITA, K</creator><scope>EVB</scope></search><sort><creationdate>20060316</creationdate><title>FORMA POSOLOGICA DE LIBERACION CONTINUA CON RECUBRIMIENTO DE LATEX Y SU PROCEDIMIENTO DE REALIZACION</title><author>ARNHOLT, BARBARA, S ; EVANS, MONTY, L ; MAZER, TERRY, B ; WALTON, JOSEPH, E ; HAMILTON, DANIEL ; GECKLE, RONITA, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2248094TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ARNHOLT, BARBARA, S</creatorcontrib><creatorcontrib>EVANS, MONTY, L</creatorcontrib><creatorcontrib>MAZER, TERRY, B</creatorcontrib><creatorcontrib>WALTON, JOSEPH, E</creatorcontrib><creatorcontrib>HAMILTON, DANIEL</creatorcontrib><creatorcontrib>GECKLE, RONITA, K</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ARNHOLT, BARBARA, S</au><au>EVANS, MONTY, L</au><au>MAZER, TERRY, B</au><au>WALTON, JOSEPH, E</au><au>HAMILTON, DANIEL</au><au>GECKLE, RONITA, K</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMA POSOLOGICA DE LIBERACION CONTINUA CON RECUBRIMIENTO DE LATEX Y SU PROCEDIMIENTO DE REALIZACION</title><date>2006-03-16</date><risdate>2006</risdate><abstract>Una unidad de forma de dosificación para administrar un agente beneficioso en un fluido, consistiendo la unidad de forma de dosificación en: un núcleo que contiene al menos un agente beneficioso dispersable en un fluido y un agente ligante compatible para unir el agente beneficioso y un revestimiento de látex que envuelve el núcleo, incluyendo el revestimiento de látex una mezcla que contiene un material básico substancialmente hidrofóbico capaz de definir una membrana de tipo matriz y al menos un componente hidrofílico dispersable en el fluido, donde el agente beneficioso es un tinte marcador, o donde el agente beneficioso es un componente saborizante fluorescente.
Dosage form unit is provided to deliver one or more beneficial agents into a fluid, such as liquid enteral nutritional product. The dosage form unit includes a core containing at least one beneficial agent, preferably a marker dye, which is dispersible in the fluid. The core also contains a compatible binding agent to bind the beneficial agent together. Additional components of the core may include a plasticizer, a standard flow agent, a lubricant, additional tableting aids and at least one hydrophilic agent. A latex coating encases the core. The latex coating includes a mixture containing a substantially hydrophobic base material, preferably formed from an emulsion of cellulose acetate microspheres, which is capable of defining a matrix-type membrane, and at least one hydrophilic component being dispersible in the fluid. A dispersible beneficial agent is preferred as one of the hydrophilic components of the latex coating to allow immediate release of the beneficial agent therefrom. A method of making the dosage form unit also is provided.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | spa |
recordid | cdi_epo_espacenet_ES2248094TT3 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | FORMA POSOLOGICA DE LIBERACION CONTINUA CON RECUBRIMIENTO DE LATEX Y SU PROCEDIMIENTO DE REALIZACION |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T21%3A46%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ARNHOLT,%20BARBARA,%20S&rft.date=2006-03-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2248094TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |